| Drug Name | Simvastatin and Gemfibrozil |
|---|---|
| Drug Class |
Anti-hyperlipidemia
|
| Risk minimization type |
Safety communication
|
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
Risk of Rhabdomyolysis/Myopathy |
| safety communication |
|